Amelioration of TMAO through probiotics and its potential role in atherosclerosis

Atherosclerosis is a major cause of mortalities and morbidities worldwide. It is associated with hyperlipidemia and inflammation, and become chronic by triggering metabolites in different metabolic pathways. Disturbance in the human gut microbiota is now considered a critical factor in the atheroscl...

Full description

Saved in:

Bibliographic Details
Published in:	Applied microbiology and biotechnology Vol. 103; no. 23-24; pp. 9217 - 9228
Main Authors:	Din, Ahmad Ud, Hassan, Adil, Zhu, Yuan, Yin, Tieying, Gregersen, Hans, Wang, Guixue
Format:	Journal Article
Language:	English
Published:	Berlin/Heidelberg Springer Berlin Heidelberg 01.12.2019 Springer Springer Nature B.V
Subjects:	Animals Arteriosclerosis Atherosclerosis Atherosclerosis - physiopathology Atherosclerosis - prevention & control biochemical pathways Biomedical and Life Sciences Biosynthesis Biotechnology Canada Cardiovascular disease Carnitine Cholesterol Choline Diabetes Diet Flavin flavin-containing monooxygenase Health aspects Heart failure Humans Hyperlipidemia Immune system Inflammation Intestinal microflora intestinal microorganisms Lecithin Life Sciences Lipids Metabolic disorders Metabolic pathways Metabolites Metabolomics Methylamines - antagonists & inhibitors Methylamines - metabolism Mice Microbial Genetics and Genomics Microbiology Microbiomes Microbiota Microbiota (Symbiotic organisms) Microorganisms microRNA MicroRNAs Mini-Review miRNA Mortality oxidation Phosphatidylcholine phosphatidylcholines Prevention Probiotics Probiotics - therapeutic use Risk factors Trimethylamine Trimethylamine-N-oxide Type 2 diabetes Canada Gut microbiota TMAO Probiotics TMA lyases Atherosclerosis
ISSN:	0175-7598, 1432-0614, 1432-0614
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!